Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, January 3, 2021

Effect of Pre‐Hospital Workflow Optimization on Treatment Delays and Clinical Outcomes in Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis

 But since you don't know how fast you have to deliver either tPA, IVT or mechanical thrombectomy to get 100% recovery, you haven't moved the needle one iota closer to solving stroke.  Please step aside and let better people than you actually solve stroke. You are playing around the edges.

Effect of Pre‐Hospital Workflow Optimization on Treatment Delays and Clinical Outcomes in Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis

First published: 02 January 2021

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/acem.14204

Abstract

Background

The prehospital phase is critical in ensuring that stroke treatment is delivered quickly and is a major source of time delay. This study sought to identify and examine Pre‐Hospital Stroke Workflow Optimizations (PSWO) and their impact on improving health systems, reperfusion rates, treatment delays, and clinical outcomes.

Methods

The authors conducted a systematic literature review and meta‐analysis by extracting data from several research databases (PubMed, Cochrane, Medline, and Embase) published since 2005. We used appropriate key search terms to identify clinical studies concerning prehospital workflow optimization, following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines.

Results

The Authors identified 27 articles that looked at the impact of pre‐hospital workflow optimizations on time and treatment parameters, 26 were included in the meta‐analysis. The PSWO were sub‐grouped into 3 categories: Improved Intravenous Thrombolysis (IVT) Triage, Large Vessel Occlusion (LVO) bypass, and Mobile Stroke Unit (MSU). The salient findings are: Improved IVT Triage led to significantly improved rates of IVT (RR=1.80; 95% CI, 1.18–2.75); however, MSU did not (RR=1.22; 95% CI, 0.98–1.52). Improved IVT Triage (SMD=‐0.82; 95% CI, ‐1.32 – ‐0.32), LVO bypass (SMD=‐0.80; 95% CI, ‐1.13– ‐0.47) and MSU (SMD=‐0.87; 95% CI, ‐1.57 – ‐0.17) were found to significantly reduce door to needle time for IVT. MSU was found to significantly reduce call to needle (SMD=‐1.41; 95% CI, ‐1.94 – ‐0.88) and onset to needle (SMD= ‐1.15; 95% CI, ‐1.74– ‐0.56) times for IVT. MSU additionally demonstrated significant reduction in door to perfusion (SMD= ‐0.72; 95% CI, ‐1.32 – ‐0.12) as well as call to perfusion (SMD= ‐0.73; 95% CI, ‐1.08– ‐0.38) times for EVT. Finally, PSWO did not demonstrate significant improvements in rates of good functional outcome (RR=1.04; 95% CI, 0.97–1.12) or mortality at 90 days (RR=1.00; 95% CI, 0.76–1.31).

Conclusions

This systematic review and meta‐analysis found that PSWO significantly improves several time metrics related to stroke treatment leading to improvement in IVT reperfusion rates. Thus, the implementation of these measures in stroke networks is a promising avenue to improve an often‐neglected aspect of the stroke response. However, the limited available data suggest functional outcomes and mortality are not significantly improved by PSWO, hence further studies and improvement strategies vis a vis PSWOs are warranted.

 

No comments:

Post a Comment